Aeon Biopharma Inc (AEON) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Aeon Biopharma inc   (NYSEAMER: AEON)


Aeon Biopharma Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aeon Biopharma Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Aeon Biopharma Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -1 2 -1 1 3
Return On Investment (TTM) - -6564.02 % - 0.43 % 11683.81 %
AEON's Overall Ranking # 4382 # 3715 # 3805 # 11 # 0
Seq. Investment Change TTM - -46.61 % - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -55 -60 -39 0 -293




Return On Investment AEON's Ranking
Within: No.
Industry # 259
Sector # 553
Overall # 4382

Return On Investment Statistics
High Average Low
132.98 %
-785.84 %
-6439.49 %
(Dec 31 2023)   (Jun 30 2026)







Financial Statements
Aeon Biopharma Inc's II. Quarter Investments $ -1 Millions AEON's Balance sheet
Aeon Biopharma Inc's II. Quarter Income $ -1 Millions Quarterly AEON's Income Statement
AEON's Income by Division See AEON's Income by Division


AEON Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2022)
2022
(Dec 31 2021)
2021

Total Investments in Millions -1 -11 -6 276 276
Y / Y Investment Growth - - - -0.18 % -
Net Income in Millions -39 42 6 8 0
Y / Y Net Income Growth - 558.87 % -22.26 % - -
Annual Return On Investment - - - 2.98 % -


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 2.98 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AEON's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AEON's Competitors
Subscribers only: Roi for Aeon Biopharma Inc's Suppliers
Subscribers only: Return On Investment for AEON's Customers

Other Ratios
AEON's Roa AEON's Inventory Turnover Ratio AEON's Growth Rates AEON's Dividend Statistics
AEON's Profitability Ratios AEON's Asset Turnover Ratio AEON's Dividend Growth
AEON's Roe AEON's Valuation Ratios AEON's Financial Strength Ratios AEON's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-03T11:27:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.